Kimberly-Clark Corp (KMB) is an American multinational personal care corporation that produces mainly paper-based consumer products. Its diverse product line includes everything from diapers and wipes to tissues, incontinence care, and professional products for the B2B market. With its roots tracing back as far as 1872, KMB has risen to become one of the leading brands in the health and hygiene industry.
The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Franklyn C. Shattuck in Neenah, Wisconsin, with $42,000 (roughly $1 million today) of capital. Initially, they produced newsprint, however, they quickly diversified into a wider variety of paper products.
The company's brands such as Kleenex facial tissue, Scott paper towels, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper are recognized globally. KMB also owns personal healthcare brand Huggies which includes baby wipes, diapers, and training pants, and Depend, Poise, and U by Kotex which offer adult incontinence and feminine products.
KMB is publicly traded on the New York Stock Exchange under the ticker symbol "KMB". The company's strong growth and solid performance have made it a favorite among investors seeking dividend income. As a member of the Dividend Aristocrats, KMB has increased its dividend for at least 25 consecutive years, a testament to the company's stability and reliability.
At the heart of Kimberly-Clark's success is their commitment to innovation, quality, and essential health products. The company is also a responsible corporate citizen. It has set various sustainability goals and is committed to reducing its environmental footprint. Its social responsibility programs include improving sanitation in developing countries, promoting health education, and reducing infant mortality.
Corporate headquarters for Kimberly-Clark Corporation remain in Irving, Texas, after moving from its historical locale of Wisconsin. The company has over 40,000 employees worldwide and operates in more than 175 countries. It reported a revenue of $19.1 billion in 2019, making it one of the largest companies in the personal care industry. Despite the competitive market, KMB continues to thrive and adapt, meeting the evolving needs and expectations of its global consumer base.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Colgate-Palmolive boasts an exceptional dividend record, having paid dividends since 1895 and raised them for 63 consecutive years, making it a Dividend King. While its cash flow comfortably covers its payouts, the company faces bifurcated growth with strong performance in Latin America and Asia Pacific but a decline in North America. Despite a solid dividend and global market share, its premium valuation suggests the stock is priced for perfection, and North America's recovery is crucial for future total returns beyond the dividend yield.
Advanced Drainage Systems (WMS) has achieved a 21.9% annualized return over the past five years. Despite this strong performance, a Discounted Cash Flow (DCF) model suggests the stock's intrinsic value is significantly above its current trading price of US$128.84, indicating it may still be undervalued. The company's future cash generation, especially its ability to convert infrastructure demand into operating cash flow, supports this potentially reasonable valuation.
BofA Securities has lowered its price target for Kimberly-Clark (KMB) to $120 from $122, while maintaining a Buy rating on the stock. This adjustment comes amidst other analyst revisions and recent news regarding Kimberly-Clark's proposed acquisition of Kenvue, for which the company is offering concessions to gain EU approval.
Procter & Gamble (PG) has launched new clinical products for its Head & Shoulders and Oral-B lines. Despite these innovations, the company's stock has seen muted performance, and one valuation model suggests it is 37% overvalued with a fair value of $107.52 against a market price of $147.39. However, an alternative Discounted Cash Flow model by Simply Wall St indicates the stock might be undervalued at $196.96, highlighting conflicting views on its true worth.
State Street Corp reduced its stake in Kimberly-Clark Corporation by 2.6% in the second quarter, selling 567,268 shares but still holding over 21 million shares valued at approximately $2.34 billion. Despite missing recent quarterly earnings and revenue expectations, analysts maintain a "Hold" rating with an average price target of $117.36, and the company declared a quarterly dividend of $1.28 per share, yielding 5.2%. Institutional investors collectively own 76.29% of the stock.
The Thornburg Investment Income Builder fund, with $23.3 billion under management, focuses on a global dividend strategy. This article highlights why the fund is invested in companies like Samsung and Citigroup, positioning it as an attractive option for investors seeking dividend income with a global scope.
Johnson & Johnson is reportedly considering selling its orthopedics unit, DePuy Synthes, for $20 billion, with Apollo Global Management as a potential buyer. This move follows the spin-off of Kenvue in 2023 and aligns with J&J's strategy to streamline operations and focus on higher-growth, higher-margin healthcare businesses. The sale would allow J&J to simplify its structure, free up capital, and accelerate its shift towards a leaner, more profitable company.
Johnson & Johnson is moving to divest its DePuy Synthes orthopedic division, potentially through a sale to Apollo Global Management for $20 billion, following its 2023 spinoff of Kenvue. This strategic move aims to transform J&J into a leaner, faster-growing, and more profitable company by focusing on higher-margin medical device and pharmaceutical businesses. Investors are optimistic that this streamlining will be rewarded by Wall Street, offering a cleaner and quicker path to enhanced growth and profitability.